Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/23/2007 | CA2642847A1 Dissolution aids for oral peptide delivery comprising a biguanide |
08/23/2007 | CA2641116A1 Aqueous pharmaceutical formulations of er.beta. selective ligands |
08/23/2007 | CA2640794A1 A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof |
08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
08/22/2007 | EP1820497A2 Effervescent bisphosphonate formulation |
08/22/2007 | EP1820495A2 Microspheres for active embolization |
08/22/2007 | EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors |
08/22/2007 | EP1819361A2 Pharmaceutical combinations |
08/22/2007 | EP1536806B1 Use of hesperidine or one of its derivatives for making a medicine for bone formation stimulation |
08/22/2007 | EP1499320B1 Novel compounds |
08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
08/22/2007 | EP1300399B1 Phenylpyridazine derivatives and drugs containing the same |
08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
08/22/2007 | EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors |
08/22/2007 | CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
08/22/2007 | CN1332973C Extraction process of conjugated female hormone |
08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
08/22/2007 | CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
08/22/2007 | CN1332701C Externally applied Chinese medicinal formulation for treating bone fracture |
08/22/2007 | CN1332679C Traditional Chinese medicine composition for treating osteoporosis, and its prepn. method |
08/22/2007 | CN1332674C Method for preparing Chinese medicinal formulation of dog button |
08/22/2007 | CN1332669C Dripping pills for reducing swelling and easing pain and its preparing method |
08/22/2007 | CN101023085A Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
08/22/2007 | CN101023072A Piperidinyl targeting compounds that selectively bind integrins |
08/22/2007 | CN101022829A Treatment of polychondritis or mononeuritis multiplex by using an antibody against CD20 |
08/22/2007 | CN101022823A Physiologically active composition based on collagen |
08/22/2007 | CN101022812A Solid and crystalline ibandronate sodium and processes for preparation thereof |
08/22/2007 | CN101022809A Dihydropteridinones for the treatment of cancer diseases |
08/22/2007 | CN101022800A Pharmaceutical composition for the treatment of bone fracture |
08/22/2007 | CN101020067A Transdermal plaster prepn for 99m TC methylene diphosphonate |
08/22/2007 | CN101020049A Use of ulinastatin in preparing medicine for treating and/or preventing spinal cord injury |
08/22/2007 | CN101020047A Health food containing calcium reinforcing agent |
08/22/2007 | CN101020032A Chinese medicine prepn for treating ischemic femoral head necrosis |
08/22/2007 | CN101020023A Chinese medicine for treating femoral head necrosis |
08/22/2007 | CN101020016A Medicine for treating fracture and injured tendon and its prepn |
08/22/2007 | CN101019976A Hot compress medicine bag for treating osteoarthrosis |
08/22/2007 | CN101019975A Fracture treating Chinese medicine composition and its prepn |
08/22/2007 | CN101019972A Liquid Chinese medicine for treating rheumatic arthritis and rheumatoil arthritis |
08/22/2007 | CN101019960A Medicine for treating femoral head necrosis |
08/22/2007 | CN101019941A Chinese medicine prepn for treating osteochondrosis of tibial tubercle and other diseases |
08/22/2007 | CN101019929A Chinese medicine composition for treating femoral head necrosis and its prepn process |
08/22/2007 | CN101019917A Lotion for trauma |
08/22/2007 | CN101019847A Slow released diacetyl rheinic acid prepn and its prepn process |
08/22/2007 | CN101019824A Oral medicine composition containing salvianolic acid and its prepn |
08/22/2007 | CN101019818A Liquid detergent composition of gleditchia horrida for washing hand and bathing and its prepn |
08/21/2007 | US7259243 Process for isolation of osteopontin from milk |
08/21/2007 | US7259187 Tropolone derivatives |
08/21/2007 | US7259179 Kinase inhibitors |
08/21/2007 | US7259171 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
08/21/2007 | US7259170 Macrolides containing pharmaceutical compositions |
08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
08/21/2007 | US7259161 For therapy of immune response, an autoimmune disease, a neurodegenerative, or a solid or hematologic malignancy |
08/21/2007 | US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders |
08/21/2007 | US7259154 Pyrrolopyrimidines |
08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
08/16/2007 | WO2007092638A1 Bicyclic sphingosine 1-phosphate analogs |
08/16/2007 | WO2007091707A1 Pharmaceutical composition for preventing and/or treating bone disease, functional food, health food, pharmaceutical preparation and tooth root-periodontal tissue formation promoting agent containing the composition |
08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
08/16/2007 | WO2007090504A1 Hydrolysed collagen and uses therof |
08/16/2007 | WO2007070547A3 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
08/16/2007 | WO2007070546A3 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects |
08/16/2007 | WO2007012841A3 Compositions comprising monobutyrin |
08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
08/16/2007 | US20070191484 Medicaments containing pantothenic acid |
08/16/2007 | US20070191468 Amino alcohol compound |
08/16/2007 | US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
08/16/2007 | US20070191311 P2x receptor inhibitor |
08/16/2007 | US20070191310 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; 1-Stearoyl-2-{3-[2-(2,6-dichloroanilino)phenylacetamido]propanoyl}-sn-glycero-3-phosphocholine |
08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
08/16/2007 | US20070191274 Active hedgehog protein conjugate |
08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
08/16/2007 | US20070190612 31 Human Secreted Proteins |
08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
08/16/2007 | DE102006005016A1 Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung Conditioned blood composition and process for their preparation |
08/16/2007 | CA2641718A1 Bicyclic sphingosine 1-phosphate analogs |
08/16/2007 | CA2640094A1 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
08/16/2007 | CA2637817A1 Vitamin d analog - nel, methods and uses thereof |
08/16/2007 | CA2637302A1 Vitamin d analog-rak, methods and uses thereof |
08/16/2007 | CA2629336A1 [4-(benzo[b]thiophen-2-yl)pyrimidin-2yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases |
08/15/2007 | EP1818343A2 Antibodies against human IL-12 |
08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
08/15/2007 | EP1818052A1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
08/15/2007 | EP1817276A1 Cathepsin cysteine protease inhibitors |
08/15/2007 | EP1817275A1 Haloalkyl containing compounds as cysteine protease inhibitors |
08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
08/15/2007 | EP1471886B1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use |